Abstract:Hye-Rin Kang, 1, &ast So Jeong Kim, 2, &ast Ju Gang Nam, 3 Young Sik Park, 4 Chang-Hoon Lee 4 1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Veteran Health Service Medical Center, Seoul, 05368, Republic of Korea; 2 Division of Pulmonology and Allergy, Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do, 18450, Republic of Korea; 3 Department of Radiology, Seoul National University Hospital, Seoul, 03080, Republic of Korea; 4 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea &astThese authors contributed equally to this work Correspondence: Chang-Hoon Lee, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-Ro Jongno-Gu, Seoul, 03080, Republic of Korea, Tel +82-2-2072-4743, Fax +82-2-762-9662, Email Introduction: Mortality differences in chronic obstructive pulmonary disease (COPD) between nonsmokers and smokers remain unclear. We compared the risk of death associated with smoking and COPD on mortality. Methods: The study included participants aged ≥ 40 years who visited pulmonary clinics and were categorised into COPD or non-COPD and smoker or nonsmoker on the basis of spirometry results and cigarette consumption. Mortality rates were compared between groups using statistical analysis for all-cause mortality, respiratory disease-related mortality, and cardiocerebrovascular disease-related mortality. Results: Among 5811 participants, smokers with COPD had a higher risk of all-cause (adjusted hazard ratio (aHR), 1.69; 95% confidence interval (CI), 1.23– 2.33) and respiratory disease-related mortality (aHR, 2.14; 95% CI, 1.20– 3.79) than nonsmokers with COPD. Non-smokers with and without COPD had comparable risks of all-cause mortality (aHR, 1.39; 95% CI, 0.98– 1.97) and respiratory disease-related mortality (aHR, 1.77; 95% CI, 0.85– 3.68). However, nonsmokers with COPD had a higher risk of cardiocerebrovascular disease-related mortality than nonsmokers without COPD (aHR, 2.25; 95% CI, 1.15– 4.40). Conclusion: The study found that smokers with COPD had higher risks of all-cause mortality and respiratory disease-related mortality compared to nonsmokers with and without COPD. Meanwhile, nonsmokers with COPD showed comparable risks of all-cause and respiratory mortality but had a higher risk of cardiocerebrovascular disease-related mortality compared to nonsmokers without COPD. Keywords: pulmonary disease, chronic obstructive, smokers, nonsmokers, cigarette smoking, comorbidity Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally. 1 COPD is persistent airflow limitation and lung tissue damage due to prolonged environmental factor exposure in individuals with a genetic predisposition. 2 Effective inhaled therapy has long been developed for COPD management. 3 Recently, inhaled triple pharmacologic therapy, combining inhaled corticosteroids (ICS), long-acting muscarinic antagonists (LAMA), and long-acting β2-agonists (LABA), has showed treatment effectiveness in severe COPD. 4 The most significant risk factor for the development of COPD is smoking. However, other factors, such as exposure to air pollutants or workplace fumes and dust, genetic factors, and repeated lower airway infections, can also cause COPD, which has been reported in nonsmokers. 5,6 Nonsmokers account for 25–45% of all patients with COPD. Studies have shown that COPD in nonsmokers displays different clinical features than that in smokers. 5,7–12 This distinction is further endorsed in GOLD 2023 which classifies COPD types in nonsmokers as different from COPD in smokers. 3 However, so far, large COPD cohort studies and trials have systematically excluded nonsmokers; therefore, the clinical characteristics and outcomes, including mortality risk in nonsmokers with COPD, have not been fully investigated. 13 A few studies 14–16 have compared mortality risk between smokers with COPD and nonsmokers with COPD. However, these studies have limitations, such as a lack of postbronchodilator spirometry results, 14,15 insufficient adjustment for covariates, 14 and a low number of participants. 16 Studies have reported that nonsmokers with COPD have a milder clinical course and airflow limitation compared with smokers with COPD. 17–19 Therefore, we hypothesized that nonsmokers with COPD show a different mortality risk compared with smokers with COPD. The aim of -Abstract Truncated-

Mortality Risks of Copd for Nonsmokers and Smokers from A Prospective Cohort Study of 390,269 Subjects in Taiwan - Assessing Involvement Beyond the Lungs

Correction To: Low-intensity Cigarette Smoking and Mortality Risks: a Pooled Analysis of Prospective Cohort Studies in Japan.

Impact of Smoking and Chronic Obstructive Pulmonary Disease on All-Cause, Respiratory, and Cardio-Cerebrovascular Mortality

COPD and risk of cardiovascular disease: A prospective study of 0.5M Chinese adults

The Impact of Lung Function on Extra-Pulmonary Diseases and All-Cause Mortality in US Adult Population with and Without COPD

Increasing Mortality Caused by Chronic Obstructive Pulmonary Disease (COPD) in Relation with Exposure to Ambient Fine Particulate Matters: an Analysis in Southeastern China

Prevalence, mortality and risk factors for self-reported COPD among smokers and never smokers, NHANES 1999-2018

Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis

An 18-Year Follow Up Study on the Risk Factors of Deaths Regarding Chronic Obstructive Pulmonary Disease in Xi'an, China

Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study

COPD and Its Association with Smoking in the Mainland China: a Cross-Sectional Analysis of 0.5 Million Men and Women from Ten Diverse Areas.

Excess Risk of Major Vascular Diseases Associated with Airflow Obstruction: a 9-Year Prospective Study of 0.5 Million Chinese Adults.

Association of chronic obstructive pulmonary disease with risk of lung cancer in individuals aged 40 years and older: A cross-sectional study based on NHANES 2013-2018

[Relationship between smoking and the risk of morbidity of chronic obstructive pulmonary diseases among residents aged 30 years and above in Sichuan Province: a prospective study]

Do Deaths from Competing Risks Influence COPD Patterns in China and High Socio-Demographic Index Countries?: a Cross-Sectional Analysis of Summary Statistics from the Global Burden of Disease Study 2017.

Smoking and mortality in an older Chinese cohort.

Smoking Cessation Affects the Natural History of COPD

Impaired Lung Function and Lung Cancer Risk in 461,183 Healthy Individuals: a Cohort Study

Secondhand smoke increases the risk of developing chronic obstructive pulmonary disease

Difference in Long-Term Trends in COPD Mortality between China and the U.S., 1992–2017: An Age–Period–Cohort Analysis

Difference In Long-Term Trends In Copd Mortality Between China And The Us, 1992-2017: An Age-Period-Cohort Analysis